Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

oral contrast agent, breast cancer, dense tissue, mammograms, American Chemical Society ACS
News | Contrast Media | March 15, 2016

March 15, 2016 — The ongoing debate about ...

lung disease, MRI scans, contrast agent, hyperpolarized krypton
News | Lung Cancer | March 11, 2016

March 11, 2016 — New scanning technology which will give a much clearer picture of...

Weill Cornell Medicine, Senior Scientific, magnetix relaxometry, MRX technology, prostate cancer detection
News | Prostate Cancer | February 18, 2016

February 18, 2016 — Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is...

Guerbet, OptiOne single-head contrast delivery system, FDA 510k clearance
Technology | Contrast Media Injectors | February 16, 2016

February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S. Food and Drug Administration...

ultrasound-activated microbubbles, heart attack, pig model, NIBIB, human clinical trials

An ultrasound-stimulated microbubble burrows through a fibrin clot (green) allowing penetration of the surrounding fluid into the clot (yellow). Image courtesy of Christopher Acconci and David Goertz, University of Toronto.

News | Ultrasound Imaging | February 11, 2016

February 11, 2016 — Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB)...

News | Contrast Media | February 04, 2016

February 4, 2016 — Akrotome Imaging Inc. received a major award from the National Institutes of Health (NIH) in...

Novel MRI Imaging Agent More Effectively Monitors Impact of Treatment in Lung, Prostate Cancers

Molecular imaging of the GRPR biomarker on mice xenografted with PC3 and H441 cells by T1-weighted spin echo MR imaging and NIR imaging.

News | Magnetic Resonance Imaging (MRI) | December 29, 2015

December 29, 2015 — A method to better trace changes in cancers and treatment of the prostate and lung without the...

smart fat cells, liposomes, blood-brain barrier, gliomas, early detection, brain tumors
News | Neuro Imaging | December 22, 2015

December 22, 2015 — A magnetic resonance imaging (MRI)...

News | Contrast Media | November 29, 2015

November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery...

Access Scientific, Powerwand midline IV catheter, CT contrast injection

Image courtesy of Access Scientific LLC

Technology | Contrast Media | November 02, 2015

November 2, 2015 — Access Scientific LLC announced validation of the Powerwand midline IV catheter for power-...

Lumason, CMS, ultrasound contrast agent, approval for reimbursement
News | Contrast Media | October 21, 2015

October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and...

Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors | October 01, 2015

October 1, 2015 — Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline...

EMI-137, optical imaging agent, detection, early stage, colorectal cancer
News | Oncology Diagnostics | September 18, 2015

September 18, 2015 — Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a...

UAMS, Vladimir Zharov, melanoma, theranostics, CTCs, nanoparticles
News | Ultrasound Imaging | September 14, 2015

September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc.,...

ultrasound, microbubbles, delivery, absorption, drugs, pancreatic cancer, ICUS
News | Contrast Media | September 11, 2015

September 11, 2015 — Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with...

NIH, biomarker, breast cancer, early detection, contrast solution, MRI

Metastasis occurs when cells are shed from primary breast cancer tumor and establish a new tumor at a distant site. For early detection of the metastasis with MRI, the Lu Lab developed a probe that binds to fibrin-fibronectin protein complexes in high-risk tumors. Fibronectin is expressed in high-risk (aggressive) cancer and not in normal tissue, so MRI imaging is able to distinguish metastases from normal tissue. Image courtesy of the National Institutes of Health.

News | MRI Breast | August 12, 2015

August 12, 2015 — Researchers have shown that...

NIR, contrast agents, thyroid, parathyroids, surgery, Frangioni, FLARE

Intraoperative image of thyroid (red) and parathyroids (green) in rats four hours after intravenous injection of targeted contrast agents. Image captured using the FLARE system. Image courtesy of Macmillan Publishers Ltd.

News | Contrast Media | July 29, 2015

July 29, 2015 — Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have...

Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
Feature | Contrast Media | July 28, 2015

July 28, 2015 — Guerbet announced that it has entered into a definitive agreement under which it will acquire...

MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue
Feature | Contrast Media | June 26, 2015

June 26, 2015 - New results in animals highlight a major safety concern regarding a class of...

molecular MRI, contrast agents, PSMA, cancer, SNMMI, Sangeeta Ray
News | June 16, 2015

June 16, 2015 - The prostate-specific membrane antigen (PSMA) biomarker is the bullseye for three new...